newsfilter
← Latest News
FDA Approved Drugs·

Approval of Dihydroergotamine Mesylate, Anda #216881

Approval Date: 06/22/2023; Drug Name: Dihydroergotamine Mesylate, Anda #216881; Active Ingredients: DIHYDROERGOTAMINE MESYLATE; Company: Rubicon; Submission Status: Approval; Application Number: 216881

Company
RUBICON
Keywords
RUBICON